Endovascular Today17h
Xeltis Receives FDA Breakthrough Device Designation for aXess Vascular Access Conduit, Begins US Pivotal Trial
Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular acce ...
Endovascular Today20h
Simcere’s Sanbexin Before Thrombectomy Studied to Improve Outcomes After AIS in TASTE-2
Simcere Pharmaceuticals Group Ltd. recently announced that findings from the TASTE-2 clinical study have shown that the admini ...